These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23060109)

  • 1. Serum levels of magnesium in sudden cardiac deaths among people with schizophrenia: hit or miss?
    Scorza FA; Albuquerque Md; Arida RM; Cysneiros RM
    Arq Neuropsiquiatr; 2012 Oct; 70(10):814-6. PubMed ID: 23060109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia and sudden cardiac death: a review.
    Koponen H; Alaräisänen A; Saari K; Pelkonen O; Huikuri H; Raatikainen MJ; Savolainen M; Isohanni M
    Nord J Psychiatry; 2008; 62(5):342-5. PubMed ID: 18752109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 consumption and sudden cardiac death in schizophrenia.
    Scorza FA; Cysneiros RM; Terra VC; Scorza CA; Cavalheiro EA; Ribeiro MO; Gattaz WF
    Prostaglandins Leukot Essent Fatty Acids; 2009 Oct; 81(4):241-5. PubMed ID: 19628381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of QTc interval and antipsychotics.
    Agelink MW
    Am J Psychiatry; 2002 Jun; 159(6):1063; author reply 1064. PubMed ID: 12042206
    [No Abstract]   [Full Text] [Related]  

  • 6. Antipsychotics and QT prolongation.
    Taylor DM
    Acta Psychiatr Scand; 2003 Feb; 107(2):85-95. PubMed ID: 12534433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antipsychotic use by patients with schizophrenia on deceleration capacity and its relation to the corrected QT interval.
    Okayasu H; Shinozaki T; Takano Y; Sugawara N; Fujii K; Yasui-Furukori N; Ozeki Y; Shimoda K
    Gen Hosp Psychiatry; 2023; 81():15-21. PubMed ID: 36716654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
    Haddad PM; Anderson IM
    Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic-induced sudden cardiac death: examination of an atypical reaction.
    Killeen MJ
    Expert Opin Drug Saf; 2009 May; 8(3):249-52. PubMed ID: 19505259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics.
    Czekalla J; Kollack-Walker S; Beasley CM
    J Clin Psychiatry; 2001; 62 Suppl 2():35-40. PubMed ID: 11232751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lengthening of QT interval by antipsychotic drugs].
    Haverkamp W; Deuschle M
    Nervenarzt; 2006 Mar; 77(3):276, 278-80, 282-4 passim. PubMed ID: 16052325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden Cardiac Death in Schizophrenia: A Review.
    Vohra J
    Heart Lung Circ; 2020 Oct; 29(10):1427-1432. PubMed ID: 32800442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid gland and cerebella lesions: New risk factors for sudden cardiac death in schizophrenia?
    Scorza FA; Cavalheiro EA; de Albuquerque M; de Albuquerque J; Cysneiros RM; Terra VC; Arida RM
    Med Hypotheses; 2011 Feb; 76(2):251-3. PubMed ID: 21051156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
    Glassman AH
    J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
    Kecskeméti V
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):5-12. PubMed ID: 15125308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotics and the risk of sudden cardiac death.
    Straus SM; Bleumink GS; Dieleman JP; van der Lei J; 't Jong GW; Kingma JH; Sturkenboom MC; Stricker BH
    Arch Intern Med; 2004 Jun; 164(12):1293-7. PubMed ID: 15226162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.
    Watanabe J; Suzuki Y; Fukui N; Ono S; Sugai T; Tsuneyama N; Someya T
    J Clin Psychopharmacol; 2012 Feb; 32(1):18-22. PubMed ID: 22198445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic agents associated with QT interval prolongation.
    Olsen KM
    J Fam Pract; 2005 Jun; Suppl():S8-S14. PubMed ID: 15938993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Magnesium and the Risk of Death From Coronary Heart Disease and Sudden Cardiac Death.
    Kieboom BC; Niemeijer MN; Leening MJ; van den Berg ME; Franco OH; Deckers JW; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26802105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.